Taking statins might change how the body handles certain proteins linked to Alzheimer’s, but it’s not clear if that means more buildup in the brain — it could just be how the body clears them from...
Strongly supported
Multiple high-quality studies back this claim.
Not medical advice. For informational purposes only. Always consult a healthcare professional.
Taking statins might change how the body handles certain proteins linked to Alzheimer’s, but it’s not clear if that means more buildup in the brain — it could just be how the body clears them from...
See the technical phrasing
Statin therapy is associated with increased plasma levels of amyloid β40 (Aβ40) (OR: 9.27, 95% CI: 0.71–17.84) and amyloid β42 (Aβ42) (OR: 2.60, 95% CI: 1.07–4.13), indicating a potential influence on amyloid metabolism, with the observed increase likely reflecting complex peripheral clearance mechanisms rather than elevated brain amyloid production.
What the research says
Supports
1 study
Study: Overview the effect of statin therapy on dementia risk, cognitive changes and its pathologic change: a systematic review and meta-analysis.
This study provides evidence supporting the claim.
Contradicts
0 studies
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies